GH

XNAS

Guardant Health, Inc.

Mkt Cap $10.3BSERVICES-MEDICAL LABORATORIES

FUNDAMENTALS

P/S

19.65

EV/EBITDA

-53.22

P/B

-117.25

EPS (TTM)

$-3.27

ROE

239.2%

ROA

-22.6%

FCF

$-237.1M

MKT CAP

$21.2B

TECHNICAL ANALYSIS

Leaning Bullish

RSI-14

62.7

Neutral

MACD

0.000

Neutral

SMA-50

$-1.00

SMA-200

$-1.00

BOLL %B

0.71

Within bands

ATR-14

$7.69

RVOL

0.43x

Low activity

MOMENTUM

+4.3%

10d +8.6% / 30d +26.2%

AI PREDICTION · 3-MONTH VIEW

▲Strong edge over the market

GH holds a similar standing over 1 and 3 months.

WHERE IT RANKS · vs 2,129 names

20-DAY

▲Top 2%#38

60-DAY

▲#5

TYPICAL 3-MO RANGE · vs S&P 500

+0.1%leans upper+1.1%

▸ Horizon detail

20dTop 2%

60d#5

1y+analyst mean$149.11-7.6%

⚡ AI INSIGHT

Our model reads GH as strong both near-term and over the next few months. Analysts agree (94% Buy) — the bull case lines up.

RECENT CATALYSTS

ANALYST_ACTIONSCanaccord Genuity main1d
ANALYST_ACTIONSMorgan Stanley main5d
ANALYST_ACTIONSCitigroup main6d
ANALYST_ACTIONSEvercore ISI Group main8d
ANALYST_ACTIONSB of A Securities main9d

REVENUE & GROWTH

$302M

Revenue

+0.1%

QoQ

+0.5%

YoY

Gross Margin

0.7%Stable

ANALYST CONSENSUS

94% Buy

33 Buy2 Hold0 Sell

Low

$93

Mean

$149

High

$200

SHORT & FLOAT

Free Float

96.2%

2.9 days to cover.

Latest Headlines

Morgan Stanley Maintains Overweight on Guardant Health, Raises Price Target to $175

Benzinga7/9/2026

Citigroup Maintains Buy on Guardant Health, Raises Price Target to $215

Benzinga7/8/2026

ValuEngine Weekly Market Summary And Commentary

SeekingAlpha7/7/2026

Evercore ISI Group Maintains Outperform on Guardant Health, Raises Price Target to $200

Benzinga7/6/2026

Guardant Health: Great Execution, But At An Excessive Premium

SeekingAlpha7/6/2026

GHTARGETTarget hit6d ago

GHTARGETTarget hit14d ago

GHTARGETTarget hit21d ago

GHTARGETTarget hit27d ago

GHTARGETTarget hit28d ago